Agilent Cell Analysis Webinar Series
View informative Agilent Cell Analysis Webinars on a variety of research subjects. Webinars may appear in multiple research areas.
Aging Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Metformin treatment for aging-induced immune cell decline |
Leena Bharath, Ph.D. Assistant Professor School of Health Sciences Merrimack College |
Seahorse XF Analyzer | November 4, 2020 |
| Mitochondrial NAD homeostasis and the control of cellular metabolism |
Nora Kory, Ph.D. Assistant Professor of Molecular Metabolism Harvard T.H. Chan School of Public Health |
Seahorse XF Analyzer | October 15, 2020 |
| Biochemical analysis in C. elegans as a model for metabolic disease and aging | Laurent Mouchiroud, PhD, École Polytechnique Fédérale de Lausanne; Riekelt H. Houtkooper, PhD, École Polytechnique Fédérale de Lausanne | Seahorse XF Analyzer | November 30, 2011 |
| Defining the Bioenergetic Metabolite Interactome in Human Subjects |
Victor M. Darley-Usmar, Ph.D. Associate Dean for Research Endowed Professor in Mitochondrial Medicine and Pathology University of Alabama at Birmingham |
Seahorse XF Analyzer | August 13, 2020 |
Assays Under Hypoxic Conditions
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| New solutions for measuring metabolism; harnessing the power of your plate reader |
James Hynes, Ph.D, Research and Development, Project Manager, Cell Analysis Division, Agilent |
Soluble Metabolic Sensor | August 1, 2018 |
| Using the XF Analyzer to measure cellular respiration and glycolysis under hypoxic conditions | George Rogers, PhD, Senior Applications Scientist Seahorse Bioscience; Brian Dranka, PhD, Senior Applications Scientist Seahorse Bioscience | Seahorse XF Analyzer | September 25, 2013 |
Cancer Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Modeling anti-tumor function of human T cells |
Michael G. Overstreet, PhD Scientist, Oncology Discovery AstraZeneca, Oncology R&D |
xCELLigence RTCA eSight | May 5, 2020 |
| Effective combination therapy targeting BACH1 and mitochondrial metabolism in breast cancer |
Jiyoung Lee, PhD Assistant Professor, Biochemistry & Molecular Medicine School of Medicine & Health Sciences George Washington University |
Seahorse XF Analyzer | April 23, 2020 |
| Revealing Cellular Metabolic Phenotype and Function Using Agilent Seahorse XF Substrate Oxidation Stress Tests | George W. Rogers, Ph.D., Research Scientist, Expert Bioassay Solutions, Cell Analysis Division, Agilent Technologies, Inc. | Seahorse XF Analyzer | March 5th, 2020 |
| The bioenergetics of immune cell persistence in the tumor microenvironment |
David Ferrick, PhD Senior Strategy Director Cell Analysis, Agilent |
Seahorse XF Analyzer | August 6, 2019 |
| Therapeutic targeting of metabolic synthetic lethality in cancer research |
Yuting Sun, PhD Institute Research Scientist MD Anderson Cancer Center |
Seahorse XF Analyzer | July 17, 2019 |
| Use of Agilent XF Seahorse technology to monitor metabolic reprogramming via OXPHOS blockade in leukemia |
Natalia Baran, MD, PhD Postdoctoral Fellow Department of Leukemia University of Texas MD Anderson Cancer Center |
Seahorse XF Analyzer | March 7, 2019 |
| Measuring ATP production rates with the Seahorse XF Analyzer | Ajit Divakaruni, Ph.D Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA) | Seahorse XF Analyzer | January 31, 2019 |
| Regulating oxygen metabolism can radiosensitize solid tumors | Nicholas Denko, Ph.D. Associate Professor, Radiation Oncology Department College of Medicine at Ohio State University | Seahorse XF Analyzer | November 29, 2018 |
| T cell metabolism in activation and exhaustion |
Greg M. Delgoffe, Ph.D, Assistant Professor, Tumor Microenvironment Center, Department of Immunology University of Pittsburgh |
Seahorse XF Analyzer | October 18, 2018 |
| Metabolic Plasticity as a Therapeutic Target |
Victor M. Darley-Usmar, PhD, Director, UAB Mitochondrial Medicine Laboratory The University of Alabama at Birmingham |
Seahorse XF Analyzer | September 26, 2018 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| It is time for a new measure of cell function: Quantifying Cellular ATP Production Rate Using Agilent Seahorse XF Technology |
David Ferrick, PhD Senior Director Marketing Cell Analysis Division, Agilent |
Seahorse XF Analyzer | May 30, 2018 |
| Metabolic reprogramming as a therapeutic strategy for cutaneous squamous cell carcinoma |
Brian Murphy, PhD. Research Scientist I, Laboratory of Elsa R. Flores, Ph.D. Department of Molecular Oncology Moffitt Cancer Center |
Seahorse XF Analyzer | May 3, 2018 |
| Fueling T cells in Immunity and Cancer |
Jeffrey Rathmell Ph.D. Co-Leader, Host-Tumor Interactions Research Program, Cornelius Vanderbilt Professor of Immunobiology in Pathology, Microbiology and Immunology Professor of Cancer Biology Director, Vanderbilt Center for Immunobiology |
Seahorse XF Analyzer | December 14, 2017 |
| Exploring the metabolism of CAR-T cells |
Roddy O'Connor, PhD University of Pennsylvania Center for Cellular Immunotherapies |
Seahorse XF Analyzer | May 2, 2017 |
| Beyond Lactate: Measuring Glycolytic Rates in Live Cells with the Agilent Seahorse XF Glycolytic Rate Assay |
Brian Dranka, Ph.D., Biology Manager, Seahorse Products, Agilent Technologies, Inc. Sarah Burroughs, Ph.D., Instrument Product Manager, Seahorse Products, Agilent Technologies, Inc. |
Seahorse XF Analyzer | April 10, 2017 |
| Measuring Functional Metabolism of Tissues in 3D | Jonathan W. Wojtkowiak, Ph.D., Moffitt Cancer Center | Seahorse XF Analyzer | November 19, 2014 |
| Metabolomics - Following the Carbons that Fuel Cancer | Ralph J. DeBerardinis, M.D., Ph.D., UT Southwestern Medical Center; Christian M. Metallo, Ph.D., Jacobs School of Engineering, UCSD ; Eyal Gottlieb, Ph.D., Beatson Institute for Cancer Research | Seahorse XF Analyzer | May 21, 2014 |
| Probe the Metabolic Depths of Tumor Spheroids Using the XFe96 Analyzer | Brian Dranka, PhD, Manager of Biology, Seahorse Bioscience | Seahorse XF Analyzer | April 30, 2014 |
| Using the XF Analyzer to measure cellular respiration and glycolysis under hypoxic conditions | George Rogers, PhD, Senior Applications Scientist Seahorse Bioscience; Brian Dranka, PhD, Senior Applications Scientist Seahorse Bioscience | Seahorse XF Analyzer | September 25, 2013 |
| Metabolic Adaptations in Fumarate Hydratase Deficient Cells | Christian Frezza, PhD, Hutchison/MRC Research Centre, Cambridge, UK | Seahorse XF Analyzer | May 29, 2013 |
| Regulation of cancer cell growth by metabolic substrates | Anne Diers, PhD, Medical College of Wisconsin | Seahorse XF Analyzer | January 24, 2013 |
| Understanding the tumor microenvironment, and its effect on tumor metabolism, progression and therapy | Robert J Gillies, PhD, Moffitt Cancer Center; Jonathan Wojtkowiak, PhD, Moffitt Cancer Center | Seahorse XF Analyzer | June 19, 2012 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
| Multidimensional control of mitochondrial energy production: learning from physiology and pathology | Rodrigue Rossignol, PhD, Université de Bordeaux | Seahorse XF Analyzer | April 27, 2011 |
| Metabolic Reprogramming Therapy in the Treatment of Cancer | Nicholas Denko, MD, PhD, Stanford University, School of Medicine | Seahorse XF Analyzer | October 27, 2010 |
| Mitochondria Regulate Cancer | Navdeep S. Chandel, PhD, Northwestern Medical School | Seahorse XF Analyzer | September 22, 2010 |
| Analysis of Glutaminolysis and Fumarate Respiration in Bcl-xL-expressing Cells | David M. Hockenbery, MD, Internal Medicine at the University of Washington | Seahorse XF Analyzer | April 14, 2010 |
| Tutorial 2: Measuring Bioenergetics in Primary Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | August 27, 2008 |
Cardiovascular Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Using Seahorse assays to probe the role of metabolic reprogramming in pulmonary vascular disease | Stephen M. Black, Professor of Medicine & Physiology Chief, Division of Translational & Regenerative Medicinen Vice Chair for Basic Research Director, Center of Lung Vascular Pathobiology, University of Arizona | Seahorse XF Analyzer | June 24, 2020 |
| SNPing in and out of the stem cell genome with CRISPR/Cas9 to investigate cardiovascular disease | Chris Denning, Professor and Head of Department for Stem Cell Biology, Director of the Centre for Biomolecular Sciences, University of Nottingham, United Kingdom |
Seahorse XF Analyzer xCELLigence RTCA instruments xCELLigence RTCA Cardio instruments |
September 24, 2019 |
| Impaired mitochondrial ß-oxidation in cardiomyocytes: role of the cardiac renin-angiotensin system and miR-208 | Margriet Ouwens Ph.D.,German Diabetes Center, DDZ,Institute for Clinical Biochemistry and Pathobiochemistry,Düsseldorf | Seahorse XF Analyzer | January 24, 2018 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
| Mitochondrial Profiling in Cells Under Physiological Conditions and In Response to Stress | Victor Darley-Usmar, PhD, University of Alabama at Birmingham | Seahorse XF Analyzer | August 4, 2010 |
| Importance of the Mitochondrial Reserve Capacity in Cardiovascular Cells Exposed to Oxidative Stress. | Brad Hill, PhD, Center for Diabetes and Obesity Research, University of Louisville | Seahorse XF Analyzer | January 20, 2010 |
| Tutorial 2: Measuring Bioenergetics in Primary Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | August 27, 2008 |
Drug Discovery
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Defining the Bioenergetic Metabolite Interactome in Human Subjects |
Victor M. Darley-Usmar, Ph.D. Associate Dean for Research Endowed Professor in Mitochondrial Medicine and Pathology University of Alabama at Birmingham |
Seahorse XF Analyzer | August 13, 2020 |
| Modeling anti-tumor function of human T cells |
Michael G. Overstreet, PhD Scientist, Oncology Discovery AstraZeneca, Oncology R&D |
xCELLigence RTCA eSight | May 5, 2020 |
| Effective combination therapy targeting BACH1 and mitochondrial metabolism in breast cancer |
Jiyoung Lee, PhD Assistant Professor, Biochemistry & Molecular Medicine School of Medicine & Health Sciences George Washington University |
Seahorse XF Analyzer | April 23, 2020 |
| Metabolic regulation of adaptive immune cell function | Sandra Milasta, PhD Senior Scientist Immunotherapy, Pre-clinical Development Elevatebio | Seahorse XF Analyzer | April 1, 2020 |
| Utilizing Early Mitochondrial Screens in Drug Safety Toxicology |
Julie Eakins Senior Research Scientist Cyprotex (an Evotec Company) |
Seahorse XF Analyzer | December 11, 2019 |
| Core metabolic pathways dictate potency and persistence in adoptive T cell therapy |
John Connolly, PhD Chief Scientific Officer, Tessa Therapeutics Ltd Research Director, Institute of Molecular and Cellular Biology (IMCB) |
Seahorse XF Analyzer Novocyte Flow Cytometers |
October 23, 2019 |
| SNPing in and out of the stem cell genome with CRISPR/Cas9 to investigate cardiovascular disease | Chris Denning, Professor and Head of Department for Stem Cell Biology, Director of the Centre for Biomolecular Sciences, University of Nottingham, United Kingdom |
Seahorse XF Analyzer xCELLigence RTCA instruments xCELLigence RTCA Cardio instruments |
September 24, 2019 |
| Therapeutic targeting of metabolic synthetic lethality in cancer research |
Yuting Sun, PhD Institute Research Scientist MD Anderson Cancer Center |
Seahorse XF Analyzer | July 17, 2019 |
| Screen out drug-induced mitochondrial toxicity in the early stages of drug development |
Karen Tilmant, PhD, Toxicologist Klaunig Lab, School of Public Health, Indiana University Bloomington, IN, USA |
Seahorse XF Analyzer | May 21, 2019 |
| Use of Agilent XF Seahorse technology to monitor metabolic reprogramming via OXPHOS blockade in leukemia |
Natalia Baran, MD, PhD Postdoctoral Fellow Department of Leukemia University of Texas MD Anderson Cancer Center |
Seahorse XF Analyzer | March 7, 2019 |
| Regulating oxygen metabolism can radiosensitize solid tumors | Nicholas Denko, Ph.D. Associate Professor, Radiation Oncology Department College of Medicine at Ohio State University | Seahorse XF Analyzer | November 29, 2018 |
| De-risk Your Drug Discovery Pipeline |
Tomomi Kiyota, PhD Scientist, Investigative Toxicology, Safety Assessment, Genentech, Inc. William Proctor, PhD DABT, Associate Director/Senior Scientist, Investigative Toxicology, Safety Assessment, Genentech, Inc. |
Seahorse XF Analyzer | November 14, 2018 |
| Metabolic Plasticity as a Therapeutic Target |
Victor M. Darley-Usmar, PhD, Director, UAB Mitochondrial Medicine Laboratory The University of Alabama at Birmingham |
Seahorse XF Analyzer | September 26, 2018 |
| Drug Discovery: Natural Products that Expand and Induce Brown Adipose Tissue using innovative Stem Cell Metabolism Assays |
Shahzad Ali, Ph.D., Senior Research Scientist Plasticell Limited |
Seahorse XF Analyzer Soluble Metabolic Sensor |
September 6, 2018 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| Using Reserve Capacity to Screen for Mitochondrial Toxicities and Biogenesis | Craig C. Beeson, PhD, Medical University of South Carolina | Seahorse XF Analyzer | March 23, 2011 |
| Tutorial: Measuring Bioenergetics in a Variety of Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | July 17, 2008 |
Cell Physiology Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Mitochondrial NAD homeostasis and the control of cellular metabolism |
Nora Kory, Ph.D. Assistant Professor of Molecular Metabolism Harvard T.H. Chan School of Public Health |
Seahorse XF Analyzer | October 15, 2020 |
| Defining the Bioenergetic Metabolite Interactome in Human Subjects |
Victor M. Darley-Usmar, Ph.D. Associate Dean for Research Endowed Professor in Mitochondrial Medicine and Pathology University of Alabama at Birmingham |
Seahorse XF Analyzer | August 13, 2020 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| The Hitchhiker's Guide to XF Bioenergetic Assays | Bradford G. Hill, PhD, University of Louisville | Seahorse XF Analyzer | May 20, 2015 |
| Determine the Metabolic Phenotype of Your Cells Using the XFp Cell Energy Phenotype Test Kit | David Ferrick Ph.D., CSO, Seahorse Bioscience | Seahorse XF Analyzer | May 20, 2015 |
| What's Fueling Mitochondria? Designing and Interpreting Pathway-Specific XF Assays | Ajit Divakaruni, PhD, Seahorse Postdoctoral Fellow, University of California, San Diego | Seahorse XF Analyzer | August 20, 2014 |
| Assessing bioenergetic function in response to oxidative stress by metabolic profiling | Brian P. Dranka, PhD, Medical College of Wisconsin | Seahorse XF Analyzer | March 27, 2012 |
| Adaptation of Microplate-based Respirometry for Hippocampal Brain Slices | Brian Polster, PhD, University of Maryland Medical School | Seahorse XF Analyzer | May 12, 2011 |
| Multidimensional control of mitochondrial energy production: learning from physiology and pathology | Rodrigue Rossignol, PhD, Université de Bordeaux | Seahorse XF Analyzer | April 27, 2011 |
| Profiling Mitochondrial Function has never been so Easy: A Tutorial on the New XF Mito Stress Test Kit | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | September 1, 2010 |
| Mitochondrial Profiling in Cells Under Physiological Conditions and In Response to Stress | Victor Darley-Usmar, PhD, University of Alabama at Birmingham | Seahorse XF Analyzer | August 4, 2010 |
| Importance of the Mitochondrial Reserve Capacity in Cardiovascular Cells Exposed to Oxidative Stress. | Brad Hill, PhD, Center for Diabetes and Obesity Research, University of Louisville | Seahorse XF Analyzer | January 20, 2010 |
| The Rate and Coupling Efficiency of Oxidative Phosphorylation in Mitochondria and Cells | Martin Brand, PhD, Buck Institute, MRC Dunn Human Nutrition Unit | Seahorse XF Analyzer | December 8, 2008 |
Immunology Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| The NLRP3 inflammasome and metabolism - chasing the connection |
Olaf Groß, PhD Professor of Experimental Neuropathology, Medical Center, University of Freiburg |
Seahorse XF Analyzer | December 3, 2020 |
| Metformin treatment for aging-induced immune cell decline |
Leena Bharath, Ph.D. Assistant Professor School of Health Sciences Merrimack College |
Seahorse XF Analyzer | November 4, 2020 |
| How intracellular metabolic change governs immunity and inflammation |
Luke O'Neill, PhD Professor (Chair of Biochemistry) Trinity College Dublin |
Seahorse XF Analyzer | May 13, 2020 |
| Modeling anti-tumor function of human T cells |
Michael G. Overstreet, PhD Scientist, Oncology Discovery AstraZeneca, Oncology R&D |
xCELLigence RTCA eSight | May 5, 2020 |
| Metabolic regulation of adaptive immune cell function | Sandra Milasta, PhD Senior Scientist Immunotherapy, Pre-clinical Development Elevatebio | Seahorse XF Analyzer | April 1, 2020 |
| Revealing Cellular Metabolic Phenotype and Function Using Agilent Seahorse XF Substrate Oxidation Stress Tests | George W. Rogers, Ph.D., Research Scientist, Expert Bioassay Solutions, Cell Analysis Division, Agilent Technologies, Inc. | Seahorse XF Analyzer | March 5th, 2020 |
| Metabolic control of macrophage (re)programming |
Jan Van den Bossche, PhD Macrophage Immunometabolism group leader in the Department of Molecular Cell Biology and Immunology at Amsterdam UMC |
Seahorse XF Analyzer | November 6, 2019 |
| Core metabolic pathways dictate potency and persistence in adoptive T cell therapy |
John Connolly, PhD Chief Scientific Officer, Tessa Therapeutics Ltd Research Director, Institute of Molecular and Cellular Biology (IMCB) |
Seahorse XF Analyzer Novocyte Flow Cytometers |
October 23, 2019 |
| The bioenergetics of immune cell persistence in the tumor microenvironment |
David Ferrick, PhD Senior Strategy Director Cell Analysis, Agilent |
Seahorse XF Analyzer | August 6, 2019 |
| What Tregs eat makes them strong and vulnerable: a new metabolic checkpoint for cancer immunotherapy research | Ping-Chih Ho, Ph.D., Assistant Professor, Department of Fundamental Oncology, University of Lausanne, Ludwig Center for Cancer Research | Seahorse XF Analyzer | June 25, 2019 |
| Exploring how Mycobacterium tuberculosis reprograms host bioenergetic metabolism |
Bridgette M Cumming, Ph.D., Research Associate, Africa Health Research Institute (AHRI) Durban, South Africa Introduction by Dr. Adrie Steyn Professor/Investigator UAB/AHRI |
Seahorse XF Analyzer | April 4, 2019 |
| Measuring ATP production rates with the Seahorse XF Analyzer | Ajit Divakaruni, Ph.D Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA) | Seahorse XF Analyzer | January 31, 2019 |
| Rapid adoption of live cell kinetics and real time biology in the design and validation of adoptive T cell strategies |
David Ferrick, Ph.D., Senior Director, Cell Analysis Division, Agilent Technologies, Inc. |
Seahorse XF Analyzer | December 11, 2018 |
| T cell metabolism in activation and exhaustion |
Greg M. Delgoffe, Ph.D, Assistant Professor, Tumor Microenvironment Center, Department of Immunology University of Pittsburgh |
Seahorse XF Analyzer | October 18, 2018 |
| Metabolic Plasticity as a Therapeutic Target |
Victor M. Darley-Usmar, PhD, Director, UAB Mitochondrial Medicine Laboratory The University of Alabama at Birmingham |
Seahorse XF Analyzer | September 26, 2018 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| It is time for a new measure of cell function: Quantifying Cellular ATP Production Rate Using Agilent Seahorse XF Technology |
David Ferrick, PhD Senior Director Marketing Cell Analysis Division, Agilent |
Seahorse XF Analyzer | May 30, 2018 |
| Quantitative analysis of neutrophil activation using Agilent Seahorse XF technology |
Brian Dranka, Ph.D. Biology Manager Seahorse XF Products Agilent Technologies, Inc. |
Seahorse XF Analyzer | March 28, 2018 |
| Fueling T cells in Immunity and Cancer |
Jeffrey Rathmell Ph.D. Co-Leader, Host-Tumor Interactions Research Program, Cornelius Vanderbilt Professor of Immunobiology in Pathology, Microbiology and Immunology Professor of Cancer Biology Director, Vanderbilt Center for Immunobiology |
Seahorse XF Analyzer | December 14, 2017 |
| Quantifying macrophage activation using Agilent Seahorse XF technology |
Brian Dranka, Ph.D. Biology Manager Seahorse XF Products Agilent Technologies, Inc. |
Seahorse XF Analyzer | September 28, 2017 |
| Beyond Lactate: Measuring Glycolytic Rates in Live Cells with the Agilent Seahorse XF Glycolytic Rate Assay |
Brian Dranka, Ph.D. Biology Manager Seahorse Products Agilent Technologies, Inc. Sarah Burroughs, Ph.D. Instrument Product Manager Seahorse Products Agilent Technologies, Inc. |
Seahorse XF Analyzer | April 10, 2017 |
| Metabolic Reprogramming in Macrophages During Inflammation |
Luke O'Neill PhD FRS Professor of Biochemistry School of Biochemistry and Immunology Trinity Biomedical Sciences Institute, Trinity College Dublin |
Seahorse XF Analyzer | September 7, 2017 |
| Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function | Duojiao Wu, M.D., Ph.D. Associate Professor in Zhongshan Hospital, Fudan University, Principle Investigator and Director of Systems Immunology Group/Platform in Shanghai Institute of Clinical Bioinformatics | Seahorse XF Analyzer | July 26, 2017 |
| Exploring the metabolism of CAR-T cells |
Roddy O'Connor, PhD University of Pennsylvania Center for Cellular Immunotherapies |
Seahorse XF Analyzer | May 2, 2017 |
| Beyond Lactate: Measuring Glycolytic Rates in Live Cells with the Agilent Seahorse XF Glycolytic Rate Assay |
Brian Dranka, Ph.D., Biology Manager, Seahorse Products, Agilent Technologies, Inc. Sarah Burroughs, Ph.D., Instrument Product Manager, Seahorse Products, Agilent Technologies, Inc. |
Seahorse XF Analyzer | April 10, 2017 |
| XF Assay Tutorial: A rapid, real-time assay to monitor T cell activation using the Agilent Seahorse XFp Analyzer | David Ferrick, Ph.D. Senior Director Seahorse, Cell Analysis Business Unit | Seahorse XF Analyzer | February 14, 2017 |
| Metabolic plasticity in T cell responses: Implications for adaptive immunity | Russell Jones Ph.D., Rosalind and Morris Goodman Cancer Centre, Department of Physiology, McGill University | Seahorse XF Analyzer | September 23, 2015 |
| Dissecting the role of energy metabolism and mitochondrial ROS in the familial autoinflammatory disease TRAPS | Martin Pelletier, PhD, NIAMS/National Institutes of Health | Seahorse XF Analyzer | April 25, 2013 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
Immunotherapy
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Modeling anti-tumor function of human T cells |
Michael G. Overstreet, PhD Scientist, Oncology Discovery AstraZeneca, Oncology R&D |
xCELLigence RTCA eSight | May 5, 2020 |
| Metabolic regulation of adaptive immune cell function | Sandra Milasta, PhD Senior Scientist Immunotherapy, Pre-clinical Development Elevatebio | Seahorse XF Analyzer | April 1, 2020 |
| Metabolic control of macrophage (re)programming |
Jan Van den Bossche, PhD Macrophage Immunometabolism group leader in the Department of Molecular Cell Biology and Immunology at Amsterdam UMC |
Seahorse XF Analyzer | November 6, 2019 |
| Core metabolic pathways dictate potency and persistence in adoptive T cell therapy |
John Connolly, PhD Chief Scientific Officer, Tessa Therapeutics Ltd Research Director, Institute of Molecular and Cellular Biology (IMCB) |
Seahorse XF Analyzer Novocyte Flow Cytometers |
October 23, 2019 |
| The bioenergetics of immune cell persistence in the tumor microenvironment |
David Ferrick, Ph.D, Senior Strategy Director Cell Analysis, Agilent |
Seahorse XF Analyzer | August 6, 2019 |
| What Tregs eat makes them strong and vulnerable: a new metabolic checkpoint for cancer immunotherapy research |
Ping-Chih Ho, Ph.D, Assistant Professor, Department of Fundamental University of Lausanne Oncology, Ludwig Center for Cancer Research |
Seahorse XF Analyzer | January 31, 2019 |
| T cell metabolism in activation and exhaustion |
Greg M. Delgoffe, Ph.D. Assistant Professor, Tumor Microenvironment Center Department of Immunology University of Pittsburgh |
Seahorse XF Analyzer | October 18, 2018 |
Mitochondrial Disease Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Assessment of metabolic reprogramming of the skin fibroblasts from patients with mitochondrial diseases using the Seahorse XF Analyzer | Yau-Huei Wei, PhD, National Yang-Ming University and Mackay Medical College; Shi-Bei Wu, PhD, National Yang-Ming University | Seahorse XF Analyzer | March 13, 2013 |
| Bioenergetic Evaluation in Mitochondrial Disorders | Massimo Zeviani, MD, PhD, The Foundation 'Carlo Besta' Institute of Neurology; Valeria Tiranti, PhD, The Foundation 'Carlo Besta' Institute of Neurology | Seahorse XF Analyzer | September 27, 2011 |
| Human Disorders of Bioenergetics | Vamsi Mootha, MD, Harvard Medical School Center for Human Genetics, Massachusetts General Hospital | Seahorse XF Analyzer | February 26, 2008 |
Methods
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Revealing Cellular Metabolic Phenotype and Function Using Agilent Seahorse XF Substrate Oxidation Stress Tests | George W. Rogers, Ph.D., Research Scientist, Expert Bioassay Solutions, Cell Analysis Division, Agilent Technologies, Inc. | Seahorse XF Analyzer | March 5th, 2020 |
| ACEA Biosciences, a new part of Agilent Technologies: Combining Live Cell Imaging with Cellular Impedance Monitoring to Enrich Your Diverse Cell-Based Assays Information |
Brandon Lamarche, Ph.D. Principle Scientist, Head of xCELLigence Application Development, ACEA Biosciences, now part of Agilent Jeff S. Xue, Ph.D. Marketing Director ACEA Biosciences, now part of Agilent |
Seahorse XF Analyzer xCELLigence RTCA instruments Novocyte Flow Cytometers |
October 8th, 2019 |
| Measuring ATP production rates with the Seahorse XF Analyzer | Ajit Divakaruni, Ph.D Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA) | Seahorse XF Analyzer | January 31, 2019 |
| Rapid adoption of live cell kinetics and real time biology in the design and validation of adoptive T cell strategies |
David Ferrick, Ph.D., Senior Director, Cell Analysis Division, Agilent Technologies, Inc. |
Seahorse XF Analyzer | December 11, 2018 |
| New solutions for measuring metabolism; harnessing the power of your plate reader |
James Hynes, Ph.D, Research and Development, Project Manager, Cell Analysis Division, Agilent |
Soluble Metabolic Sensor | August 1, 2018 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| It is time for a new measure of cell function: Quantifying Cellular ATP Production Rate Using Agilent Seahorse XF Technology |
David Ferrick, PhD Senior Director Marketing Cell Analysis Division, Agilent |
Seahorse XF Analyzer | May 30, 2018 |
| Measuring platelet bioenergetic function - from marker to mechanism of disease | Sruti Shiva, Ph.D., Associate Professor, University of Pittsburgh | Seahorse XF Analyzer | April 20, 2016 |
| Seahorse Metabolic Analyzers Enable Rapid, Quantitative Measurement of Cellular Bioenergetics | David A. Ferrick, PhD, Chief Scientific Officer, Seahorse Bioscience | Seahorse XF Analyzer | January 21, 2016 |
| Measuring cells' dependency and flexibility on the three most abundant fuels in the body: glucose, glutamine and fatty acids | David Ferrick, Ph.D., Chief Scientific Officer, Seahorse Bioscience | Seahorse XF Analyzer | October 21, 2015 |
| Mitochondrial Control in Health & Disease | Victor Darley-Usmar, PhD, Endowed Professor of Mitochondrial Medicine and Pathology University of Alabama at Birmingham; Marcia Haigis, PhD, Associate Professor, Department of Cell Biology Harvard Medical School; Erika L. Pearce, PhD, Associate Professor Washington University School of Medicine | Seahorse XF Analyzer | June 25, 2015 |
| Determine the Metabolic Phenotype of Your Cells Using the XFp Cell Energy Phenotype Test Kit | David Ferrick Ph.D., CSO, Seahorse Bioscience | Seahorse XF Analyzer | May 20, 2015 |
| Measuring Functional Metabolism of Tissues in 3D | Jonathan W. Wojtkowiak, Ph.D., Moffitt Cancer Center | Seahorse XF Analyzer | November 19, 2014 |
| What's Fueling Mitochondria? Designing and Interpreting Pathway-Specific XF Assays | Ajit Divakaruni, PhD, Seahorse Postdoctoral Fellow, University of California, San Diego | Seahorse XF Analyzer | August 20, 2014 |
| Probe the Metabolic Depths of Tumor Spheroids Using the XFe96 Analyzer | Brian Dranka, PhD, Manager of Biology, Seahorse Bioscience | Seahorse XF Analyzer | April 30, 2014 |
| Using the XF Analyzer to measure cellular respiration and glycolysis under hypoxic conditions | George Rogers, PhD, Senior Applications Scientist Seahorse Bioscience; Brian Dranka, PhD, Senior Applications Scientist Seahorse Bioscience | Seahorse XF Analyzer | September 25, 2013 |
| Using a novel permeabilization reagent to uncover mechanisms of mitochondrial dysfunction | Anne Murphy, PhD, University of California; Ajit S. Divakaruni, PhD, University of California; George Rogers, PhD, Seahorse Bioscience | Seahorse XF Analyzer | February 27, 2013 |
| The Hitchhiker's Guide to XF Bioenergetic Assays | Bradford G. Hill, PhD, University of Louisville | Seahorse XF Analyzer | August 15, 2012 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
| Profiling Mitochondrial Function has never been so Easy: A Tutorial on the New XF Mito Stress Test Kit | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | September 1, 2010 |
| Assaying Isolated Mitochondria in the Seahorse XF24: Learning More while Requiring Less | Anne Murphy, PhD, University of California at San Diego | Seahorse XF Analyzer | October 28, 2009 |
| How to Measure Mitochondrial Function in Whole Islets. Sensing the nutrient sensor: measuring bioenergetic parameters from intact mouse and human islets of langerhans | Orian Shirihai, MD, PhD, Boston University Medical Center | Seahorse XF Analyzer | July 16, 2009 |
| Tutorial 2: Measuring Bioenergetics in Primary Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | August 27, 2008 |
| Tutorial: Measuring Bioenergetics in a Variety of Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | July 17, 2008 |
Model Organisms
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Biochemical analysis in C. elegans as a model for metabolic disease and aging | Laurent Mouchiroud, PhD, École Polytechnique Fédérale de Lausanne; Riekelt H. Houtkooper, PhD, École Polytechnique Fédérale de Lausanne | Seahorse XF Analyzer | November 30, 2011 |
Neurobiology Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Measuring ATP production rates with the Seahorse XF Analyzer | Ajit Divakaruni, Ph.D Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA) | Seahorse XF Analyzer | January 31, 2019 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| Metabolic switches that drive stem cell specification and differentiation to a mature neuron | Eva Szabo MSc, PhD, Canada Research Chair in Metabolism in Human Stem Cells and Cancer Development, Principal Investigator - Stem Cell and Cancer Research Institute (SCC-RI), Assistant Professor - Biochemistry and Biomedical Sciences and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University | Seahorse XF Analyzer | February 28, 2018 |
| Combining Seahorse XF Analysis with Stable Isotope Tracing to Reveal Novel Metabolic Drug Targets | Ajit Divakaruni, Ph.D., Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA) | Seahorse XF Analyzer | July 20, 2017 |
| Mitochondrial pyruvate metabolism controls neuronal function and excitotoxic death |
Ajit S. Divakaruni, PhD Asst. Professor of Molecular and Medical Pharmacology University of California, Los Angeles Anne N. Murphy, PhD Professor of Pharmacology University of California, San Diego |
Seahorse XF Analyzer | April 20, 2017 |
| Defining the Critical Bioenergetic Function of Huntingtin Protein | Steven Gross, Ph.D.,, Professor of Pharmacology, Weill Cornell Medical College, New York, NY. | Seahorse XF Analyzer | October 18, 2016 |
| Abnormal Respiratory Function in Autism Immune Cells | Shannon Rose, Ph.D., Arkansas Children's Hospital Research Institute | Seahorse XF Analyzer | July 23, 2014 |
| The Mitochondrial Connection from Bench to Bedside: Strategies to Prevent, Delay and Treat Alzheimer's Disease | Roberta Diaz Brinton, PhD, Professor of Pharmacology & Pharmaceutical Sciences, Biomedical Engineering and Neurology, USC | Seahorse XF Analyzer | October 31, 2013 |
| Programming the Mitochondrial Choice of Fuel Substrates: Metabolic Control of Neuronal Excitability | Nika Danial, PhD, Dana-Farber Cancer Institute | Seahorse XF Analyzer | April 17, 2012 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
| Adaptation of Microplate-based Respirometry for Hippocampal Brain Slices | Brian Polster, PhD, University of Maryland Medical School | Seahorse XF Analyzer | May 12, 2011 |
| Multidimensional control of mitochondrial energy production: learning from physiology and pathology | Rodrigue Rossignol, PhD, Université de Bordeaux | Seahorse XF Analyzer | April 27, 2011 |
| Tutorial: Measuring Bioenergetics in a Variety of Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | July 17, 2008 |
Obesity, Diabetes, & Metabolic Disorders
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Drug Discovery: Natural Products that Expand and Induce Brown Adipose Tissue using innovative Stem Cell Metabolism Assays |
Shahzad Ali, Ph.D., Senior Research Scientist Plasticell Limited |
Seahorse XF Analyzer Soluble Metabolic Sensor |
September 6, 2018 |
| It is time for a new measure of cell function: Quantifying Cellular ATP Production Rate Using Agilent Seahorse XF Technology |
David Ferrick, PhD Senior Director Marketing Cell Analysis Division, Agilent |
Seahorse XF Analyzer | May 30, 2018 |
| Impaired mitochondrial ß-oxidation in cardiomyocytes: role of the cardiac renin-angiotensin system and miR-208 | Margriet Ouwens Ph.D.,German Diabetes Center, DDZ,Institute for Clinical Biochemistry and Pathobiochemistry,Düsseldorf | Seahorse XF Analyzer | January 24, 2018 |
| Mitochondrial Bioenergetics in Diabetic Cardiomyopathy | E. Dale Abel MD PhD, University of Utah School of Medicine | Seahorse XF Analyzer | December 14, 2011 |
| Biochemical analysis in C. elegans as a model for metabolic disease and aging | Laurent Mouchiroud, PhD, École Polytechnique Fédérale de Lausanne; Riekelt H. Houtkooper, PhD, École Polytechnique Fédérale de Lausanne | Seahorse XF Analyzer | November 30, 2011 |
| Using Reserve Capacity to Screen for Mitochondrial Toxicities and Biogenesis | Craig C. Beeson, PhD, Medical University of South Carolina | Seahorse XF Analyzer | March 23, 2011 |
| How to Measure Mitochondrial Function in Whole Islets. Sensing the nutrient sensor: measuring bioenergetic parameters from intact mouse and human islets of langerhans | Orian Shirihai, MD, PhD, Boston University Medical Center | Seahorse XF Analyzer | July 16, 2009 |
| Tutorial: Measuring Bioenergetics in a Variety of Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | July 17, 2008 |
Stem Cell Biology
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| SNPing in and out of the stem cell genome with CRISPR/Cas9 to investigate cardiovascular disease | Chris Denning, Professor and Head of Department for Stem Cell Biology, Director of the Centre for Biomolecular Sciences, University of Nottingham, United Kingdom |
Seahorse XF Analyzer xCELLigence RTCA instruments xCELLigence RTCA Cardio instruments |
September 24, 2019 |
| Drug Discovery: Natural Products that Expand and Induce Brown Adipose Tissue using innovative Stem Cell Metabolism Assays |
Shahzad Ali, Ph.D., Senior Research Scientist Plasticell Limited |
Seahorse XF Analyzer Soluble Metabolic Sensor |
September 6, 2018 |
| Metabolic switches that drive stem cell specification and differentiation to a mature neuron | Eva Szabo MSc, PhD, Canada Research Chair in Metabolism in Human Stem Cells and Cancer Development, Principal Investigator - Stem Cell and Cancer Research Institute (SCC-RI), Assistant Professor - Biochemistry and Biomedical Sciences and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University | Seahorse XF Analyzer | February 28, 2018 |
| iPSC-derived neural cells for drug discovery of mitochondrial disorders |
Alessandro Prigione, M.D, Ph.D. Independent Team Leader Max Delbrueck Center for Molecular Medicine (MDC) in Berlin |
Seahorse XF Analyzer | October 26, 2017 |
| Systems-based approach to characterizing human pluripotent stem cell metabolism | Hui (Sunny) Zhang, Research Professor, Zhongshan Medical School Sun Yat-sen University in Guangzhou, China | Seahorse XF Analyzer | June 20, 2017 |
| Working Towards Defining a Metabolic Roadmap for Stem Cell Lineage Progression | Dr. James Ryall, Department of Physiology, The University of Melbourne | Seahorse XF Analyzer | May 16, 2017 |
| XF Glycolysis Stress Test Assesses Glycolysis and Glycolytic Capacity in Cells | Min Wu, PhD, Seahorse Bioscience | Seahorse XF Analyzer | August 30, 2011 |
| An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate | Atan Gross Ph.D., Weizmann Institute of Science, University in Rehovot, Israel | Seahorse XF Analyzer | May 12, 2011 |
Toxicology Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Utilizing Early Mitochondrial Screens in Drug Safety Toxicology |
Julie Eakins Senior Research Scientist Cyprotex (an Evotec Company) |
Seahorse XF Analyzer | December 11, 2019 |
| Screen out drug-induced mitochondrial toxicity in the early stages of drug development |
Karen Tilmant, PhD Toxicologist, Klaunig Lab, School of Public Health, Indiana University. Bloomington, IN, USA |
Seahorse XF Analyzer | May 21, 2019 |
| Assessment of Mitochondrial Toxicity - Workflow Advantages from Direct Measurement of Mitochondrial Function |
Daniel Gebhard EMEA-Product Specialist Cell Analysis Agilent Technologies |
Seahorse XF Analyzer | February, 2019 |
| De-risk Your Drug Discovery Pipeline |
Tomomi Kiyota, PhD Scientist, Investigative Toxicology, Safety Assessment, Genentech, Inc. William Proctor, PhD DABT, Associate Director/Senior Scientist, Investigative Toxicology, Safety Assessment, Genentech, Inc. |
Seahorse XF Analyzer | November 14, 2018 |
| New solutions for measuring metabolism; harnessing the power of your plate reader |
James Hynes, Ph.D, Research and Development, Project Manager, Cell Analysis Division, Agilent |
Soluble Metabolic Sensor | August 1, 2018 |
| Normalizing Your Seahorse XF Data with Automated Cell Counting |
Brian Dranka, Ph.D. Biology Manager Cell Analysis Division, Agilent |
Seahorse XF Analyzer | June 20, 2018 |
| Using Reserve Capacity to Screen for Mitochondrial Toxicities and Biogenesis | Craig C. Beeson, PhD, Medical University of South Carolina | Seahorse XF Analyzer | March 23, 2011 |
| Tutorial: Measuring Bioenergetics in a Variety of Cell Types | David Ferrick, PhD, CSO, Seahorse Bioscience | Seahorse XF Analyzer | July 17, 2008 |
Translational Research
| Title | Presenters | Analysis Platform | Date |
|---|---|---|---|
| Using Agilent Seahorse XF Technology to Study Energy Metabolism in Mycobacterium tuberculosis | Adrie Steyn, Ph.D., Investigator, KwaZulu-Natal Research Institute for Tuberculosis & HIV (K-RITH), Durban, South Africa | Seahorse XF Analyzer | September 14, 2016 |
| Characterization of Potential Bioenergetic Medicine Agents | Russell Swerdlow, MD, University of Kansas Medical Center | Seahorse XF Analyzer | February 24, 2016 |
| The Mitochondrial Connection from Bench to Bedside: Strategies to Prevent, Delay and Treat Alzheimer's Disease | Roberta Diaz Brinton, PhD, Professor of Pharmacology & Pharmaceutical Sciences, Biomedical Engineering and Neurology, USC | Seahorse XF Analyzer | October 31, 2013 |
| Mitochondria - the Powerhouse of the Cell Goes from Bench to Bedside | Victor Darley-Usmar, PhD, Professor Dept. of Pathology University of Alabama at Birmingham | Seahorse XF Analyzer | August 28, 2013 |
| How to Measure Mitochondrial Function in Whole Islets. Sensing the nutrient sensor: measuring bioenergetic parameters from intact mouse and human islets of langerhans | Orian Shirihai, MD, PhD, Boston University Medical Center | Seahorse XF Analyzer | July 16, 2009 |
| Human Disorders of Bioenergetics | Vamsi Mootha, MD, Harvard Medical School Center for Human Genetics, Massachusetts General Hospital | Seahorse XF Analyzer | February 26, 2008 |